Between 2002 and 2016, rates of infective endocarditis doubled, with
much of the increase occurring in young, poor, white men who also
tended to have higher rates of alcohol abuse, hepatitis C and HIV,
the study authors report in the Journal of the American Heart
Association.
"Infective endocarditis is a very serious infection ... that can
lead to heart failure, valve destruction, stroke and even death,"
said Dr. Serge Harb of the Cleveland Clinic's Heart and Vascular
Institute in Ohio, the study's senior author.
The infection typically can't be treated with antibiotics or heart
surgery alone, he added. Multidisciplinary care is often needed to
treat the heart, drug addiction and other complications, and the
cost and time can add up quickly. Patients often need to be
readmitted for subsequent episodes as well.
"Patients affected are vulnerable: they are young, have low income
and commonly have other serious infections," he told Reuters Health
by email. "They need help."
Harb and colleagues analyzed data from the largest publicly
available inpatient database in the U.S., which records information
about millions of hospital stays each year. They looked at nearly 1
million cases between 2002 and 2016 that had a primary or secondary
diagnosis of infective endocarditis, including about 94,000, or 10%,
with a drug abuse diagnosis as well.
Nationwide during that period, the proportion of patients
hospitalized with infective endocarditis who also had a diagnosis of
drug abuse doubled from 8% to 16%. The increase occurred in all U.S.
regions but was greatest in the Midwest and West.
Nationally, the average age of patients with infective endocarditis
was 68, but among those who also had drug abuse diagnoses, it was
38.
Intravenous drug use is a particular risk factor for infective
endocarditis, the study team notes.
[to top of second column] |
The subset of younger patients with concurrent drug abuse was most
often male, on Medicaid, and in the lowest quartile of median
household income. They also more often underwent cardiac or valve
surgery, had a longer stay in the hospital and higher
hospitalization costs.
"Infective endocarditis related to substance abuse is a nationwide
epidemic," Harb said. "Nationwide public health measures and
multidisciplinary teams are needed to address this rapidly growing
nationwide problem."
A limitation of the study, the study authors note, is that the
database only provided a geographical breakdown by region rather
than state or urban versus rural communities, which would be helpful
in identifying clusters or "hot zones."
Future research should look at relapse and reinfection related to
treatment and surgical intervention, said Dr. Peyman Benharash of
the University of California, Los Angeles, who wasn't involved in
the study.
"It's become a huge ethical debate about reinfection of the valves
and what to do," he told Reuters Health by phone. "Do you offer a
second operation?"
After surgery, for instance, patients must take antibiotics, often
intravenously, for several weeks. Since patients are discharged home
with the intravenous line, doctors worry that those who haven't
recovered from their substance abuse problems may continue to inject
by using it at home, Benharash said. However, physicians can't keep
patients at the hospital for weeks at a time to monitor their
progress and recovery.
"Consumers need to get behind societal programs that help people get
treated," he said. "This can happen on a national level but also at
the local level where families can provide support."
SOURCE: https://bit.ly/2OdysIl Journal of the American Heart
Association, online September 18, 2019.
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |